Latest News about APLS
Recent news which mentions APLS
Apellis Shares Climb As FDA Accepts Geographic Atrophy Candidate Submission Under Priority Review
July 19, 2022
Tickers
APLS
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Goldman Sachs Maintains Buy Rating for Apellis Pharmaceuticals: Here's What You Need To Know
May 24, 2022
Tickers
APLS
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Apellis' Pegcetacoplan Showed Continuous, Meaningful Effects At Month 18 In Geographic Atrophy Studies
March 16, 2022
Tickers
APLS
From Benzinga
From Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
From Benzinga
From Benzinga
The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO
December 15, 2021
From Benzinga
What 9 Analyst Ratings Have To Say About Apellis Pharmaceuticals
December 08, 2021
Tickers
APLS
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021
December 08, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.